Copyright Reports & Markets. All rights reserved.

Global Viral Inactivation Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Viral Inactivation Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Viral Inactivation Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Kits and Reagents
    • 1.4.3 Services
    • 1.4.4 Viral Inactivation Systems and Accessories
  • 1.5 Market by Application
    • 1.5.1 Global Viral Inactivation Market Share by Application: 2020 VS 2026
    • 1.5.2 Blood and Blood Products
    • 1.5.3 Cellular and Gene Therapy Products
    • 1.5.4 Stem Cell Products
    • 1.5.5 Tissue and Tissue Products
    • 1.5.6 Vaccines and Therapeutics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Viral Inactivation Market Perspective (2015-2026)
  • 2.2 Global Viral Inactivation Growth Trends by Regions
    • 2.2.1 Viral Inactivation Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Viral Inactivation Historic Market Share by Regions (2015-2020)
    • 2.2.3 Viral Inactivation Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Viral Inactivation Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Viral Inactivation Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Viral Inactivation Players by Market Size
    • 3.1.1 Global Top Viral Inactivation Players by Revenue (2015-2020)
    • 3.1.2 Global Viral Inactivation Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Viral Inactivation Market Concentration Ratio
    • 3.2.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2019
  • 3.3 Viral Inactivation Key Players Head office and Area Served
  • 3.4 Key Players Viral Inactivation Product Solution and Service
  • 3.5 Date of Enter into Viral Inactivation Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Viral Inactivation Historic Market Size by Type (2015-2020)
  • 4.2 Global Viral Inactivation Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Viral Inactivation Market Size by Application (2015-2020)
  • 5.2 Global Viral Inactivation Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Viral Inactivation Market Size (2015-2020)
  • 6.2 Viral Inactivation Key Players in North America (2019-2020)
  • 6.3 North America Viral Inactivation Market Size by Type (2015-2020)
  • 6.4 North America Viral Inactivation Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Viral Inactivation Market Size (2015-2020)
  • 7.2 Viral Inactivation Key Players in Europe (2019-2020)
  • 7.3 Europe Viral Inactivation Market Size by Type (2015-2020)
  • 7.4 Europe Viral Inactivation Market Size by Application (2015-2020)

8 China

  • 8.1 China Viral Inactivation Market Size (2015-2020)
  • 8.2 Viral Inactivation Key Players in China (2019-2020)
  • 8.3 China Viral Inactivation Market Size by Type (2015-2020)
  • 8.4 China Viral Inactivation Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Viral Inactivation Market Size (2015-2020)
  • 9.2 Viral Inactivation Key Players in Japan (2019-2020)
  • 9.3 Japan Viral Inactivation Market Size by Type (2015-2020)
  • 9.4 Japan Viral Inactivation Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Viral Inactivation Market Size (2015-2020)
  • 10.2 Viral Inactivation Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Viral Inactivation Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Viral Inactivation Market Size by Application (2015-2020)

11 India

  • 11.1 India Viral Inactivation Market Size (2015-2020)
  • 11.2 Viral Inactivation Key Players in India (2019-2020)
  • 11.3 India Viral Inactivation Market Size by Type (2015-2020)
  • 11.4 India Viral Inactivation Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Viral Inactivation Market Size (2015-2020)
  • 12.2 Viral Inactivation Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Viral Inactivation Market Size by Type (2015-2020)
  • 12.4 Central & South America Viral Inactivation Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Danaher
    • 13.1.1 Danaher Company Details
    • 13.1.2 Danaher Business Overview
    • 13.1.3 Danaher Viral Inactivation Introduction
    • 13.1.4 Danaher Revenue in Viral Inactivation Business (2015-2020))
    • 13.1.5 Danaher Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview
    • 13.2.3 Merck Viral Inactivation Introduction
    • 13.2.4 Merck Revenue in Viral Inactivation Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 Parker Hannifin
    • 13.3.1 Parker Hannifin Company Details
    • 13.3.2 Parker Hannifin Business Overview
    • 13.3.3 Parker Hannifin Viral Inactivation Introduction
    • 13.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2015-2020)
    • 13.3.5 Parker Hannifin Recent Development
  • 13.4 Sartorius
    • 13.4.1 Sartorius Company Details
    • 13.4.2 Sartorius Business Overview
    • 13.4.3 Sartorius Viral Inactivation Introduction
    • 13.4.4 Sartorius Revenue in Viral Inactivation Business (2015-2020)
    • 13.4.5 Sartorius Recent Development
  • 13.5 SGS
    • 13.5.1 SGS Company Details
    • 13.5.2 SGS Business Overview
    • 13.5.3 SGS Viral Inactivation Introduction
    • 13.5.4 SGS Revenue in Viral Inactivation Business (2015-2020)
    • 13.5.5 SGS Recent Development
  • 13.6 Charles River Laboratories International
    • 13.6.1 Charles River Laboratories International Company Details
    • 13.6.2 Charles River Laboratories International Business Overview
    • 13.6.3 Charles River Laboratories International Viral Inactivation Introduction
    • 13.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2015-2020)
    • 13.6.5 Charles River Laboratories International Recent Development
  • 13.7 Clean Cells
    • 13.7.1 Clean Cells Company Details
    • 13.7.2 Clean Cells Business Overview
    • 13.7.3 Clean Cells Viral Inactivation Introduction
    • 13.7.4 Clean Cells Revenue in Viral Inactivation Business (2015-2020)
    • 13.7.5 Clean Cells Recent Development
  • 13.8 Rad Source Technologies
    • 13.8.1 Rad Source Technologies Company Details
    • 13.8.2 Rad Source Technologies Business Overview
    • 13.8.3 Rad Source Technologies Viral Inactivation Introduction
    • 13.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2015-2020)
    • 13.8.5 Rad Source Technologies Recent Development
  • 13.9 Texcell
    • 13.9.1 Texcell Company Details
    • 13.9.2 Texcell Business Overview
    • 13.9.3 Texcell Viral Inactivation Introduction
    • 13.9.4 Texcell Revenue in Viral Inactivation Business (2015-2020)
    • 13.9.5 Texcell Recent Development
  • 13.10 Viral Inactivated Plasma Systems
    • 13.10.1 Viral Inactivated Plasma Systems Company Details
    • 13.10.2 Viral Inactivated Plasma Systems Business Overview
    • 13.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
    • 13.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2015-2020)
    • 13.10.5 Viral Inactivated Plasma Systems Recent Development
  • 13.11 Wuxi Pharmatech (Cayman)
    • 10.11.1 Wuxi Pharmatech (Cayman) Company Details
    • 10.11.2 Wuxi Pharmatech (Cayman) Business Overview
    • 10.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
    • 10.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2015-2020)
    • 10.11.5 Wuxi Pharmatech (Cayman) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Viral Inactivation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Inactivation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Danaher
    Merck
    Parker Hannifin
    Sartorius
    SGS
    Charles River Laboratories International
    Clean Cells
    Rad Source Technologies
    Texcell
    Viral Inactivated Plasma Systems
    Wuxi Pharmatech (Cayman)

    Market segment by Type, the product can be split into
    Kits and Reagents
    Services
    Viral Inactivation Systems and Accessories
    Market segment by Application, split into
    Blood and Blood Products
    Cellular and Gene Therapy Products
    Stem Cell Products
    Tissue and Tissue Products
    Vaccines and Therapeutics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now